Arcellx, Inc.
US ˙ NasdaqGS ˙ US03940C1009

Introduction

This page provides a comprehensive analysis of the known insider trading history of Andrew H Galligan. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Andrew H Galligan has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:OOMA / Ooma, Inc. Director 241,081
US:ACLX / Arcellx, Inc. Director 5,000
US:NVRO / Nevro Corp. Chief Financial Officer 59,179
US:DDXS / Diadexus, Inc. Director 60,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Andrew H Galligan. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ACLX / Arcellx, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACLX / Arcellx, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACLX / Arcellx, Inc. Insider Trades
Insider Sales ACLX / Arcellx, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACLX / Arcellx, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACLX / Arcellx, Inc. Insider Trades
Insider Purchases OOMA / Ooma, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACLX / Arcellx, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OOMA / Ooma, Inc. Insider Trades
Insider Sales OOMA / Ooma, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACLX / Arcellx, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-06-23 OOMA Galligan Andrew H 12,407 12.4346 12,407 12.4346 154,276 49 10.9800 -18,047 -11.70
2024-12-17 OOMA Galligan Andrew H 14,824 14.5600 14,824 14.5600 215,837
2019-09-23 OOMA Galligan Andrew H 25,000 10.4960 25,000 10.4960 262,400
2019-09-10 OOMA Galligan Andrew H 25,000 12.3062 25,000 12.3062 307,655

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OOMA / Ooma, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Andrew H Galligan as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-06-24 2025-06-23 4 OOMA OOMA INC
Common Stock
S - Sale -12,407 241,081 -4.89 12.43 -154,276 2,997,746
2025-06-09 2025-06-05 4 OOMA OOMA INC
Common Stock
A - Award 11,556 253,488 4.78
2025-03-20 3 ACLX Arcellx, Inc.
Common Stock
5,000
2024-12-19 2024-12-17 4 OOMA OOMA INC
Common Stock
S - Sale -14,824 241,932 -5.77 14.56 -215,837 3,522,530
2024-12-19 2024-12-17 4 OOMA OOMA INC
Common Stock
M - Exercise 35,000 256,756 15.78 6.04 211,400 1,550,806
2024-06-07 2024-06-06 4 OOMA OOMA INC
Common Stock
A - Award 19,762 221,833 9.78
2023-06-05 2023-06-01 4 OOMA OOMA INC
Common Stock
A - Award 11,783 202,071 6.19
2022-06-03 2022-06-01 4 OOMA OOMA INC
Common Stock
A - Award 11,355 190,288 6.35
2021-06-04 2021-06-02 4 OOMA OOMA INC
Common Stock
A - Award 7,498 178,933 4.37
2020-06-08 2020-06-04 4 NVRO NEVRO CORP
Common Stock
F - Taxes -2,311 59,179 -3.76 121.53 -280,856 7,192,024
2020-06-05 2020-06-03 4 OOMA OOMA INC
Common Stock
A - Award 10,451 171,435 6.49
2020-03-03 2020-02-28 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -8,000 33,394 -19.33
2020-03-03 2020-02-28 4 NVRO NEVRO CORP
Common Stock
M - Exercise 8,000 61,490 14.96 3.60 28,800 221,364
2020-01-10 2020-01-08 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -17,718 0 -100.00
2020-01-10 2020-01-08 4 NVRO NEVRO CORP
Common Stock
S - Sale X -17,718 53,490 -24.88 120.11 -2,128,086 6,424,614
2020-01-10 2020-01-08 4 NVRO NEVRO CORP
Common Stock
M - Exercise 17,718 71,208 33.12 63.23 1,120,309 4,502,482
2020-01-08 2020-01-06 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -2,782 17,718 -13.57
2020-01-08 2020-01-06 4 NVRO NEVRO CORP
Common Stock
S - Sale X -2,782 53,490 -4.94 120.00 -333,840 6,418,800
2020-01-08 2020-01-06 4 NVRO NEVRO CORP
Common Stock
M - Exercise 2,782 56,272 5.20 63.23 175,906 3,558,079
2019-11-26 2019-11-25 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -12,000 20,500 -36.92
2019-11-26 2019-11-25 4 NVRO NEVRO CORP
Common Stock
S - Sale X -12,000 53,490 -18.32 110.39 -1,324,714 5,904,911
2019-11-26 2019-11-25 4 NVRO NEVRO CORP
Common Stock
M - Exercise 12,000 65,490 22.43 63.23 758,760 4,140,933
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -12,000 32,500 -26.97
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -6,522 14,941 -30.39
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,175 53,490 -2.15 104.74 -123,075 5,602,799
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -10,345 54,665 -15.91 103.85 -1,074,287 5,676,742
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -7,002 65,010 -9.72 103.31 -723,369 6,716,112
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
M - Exercise 12,000 72,012 20.00 63.23 758,760 4,553,319
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
M - Exercise 6,522 60,012 12.19 18.00 117,396 1,080,216
2019-11-05 2019-11-01 4 NVRO NEVRO CORP
Common Stock
F - Taxes -1,713 53,490 -3.10 86.63 -148,397 4,633,839
2019-09-23 2019-09-23 4 OOMA OOMA INC
Common Stock
S - Sale -25,000 160,984 -13.44 10.50 -262,400 1,689,688
2019-09-11 2019-09-10 4 OOMA OOMA INC
Common Stock
S - Sale -25,000 185,984 -11.85 12.31 -307,655 2,288,756
2019-07-17 2019-07-16 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -2,500 41,394 -5.70
2019-07-17 2019-07-16 4 NVRO NEVRO CORP
Common Stock
M - Exercise 2,500 55,203 4.74 3.60 9,000 198,731
2019-07-09 2019-07-08 4 OOMA OOMA INC
Stock Option (right to buy)
M - Exercise -114,943 0 -100.00
2019-07-09 2019-07-08 4 OOMA OOMA INC
Stock Option (right to buy)
M - Exercise -19,157 0 -100.00
2019-07-09 2019-07-08 4 OOMA OOMA INC
Common Stock
M - Exercise 114,943 210,984 119.68 0.90 103,449 189,886
2019-07-09 2019-07-08 4 OOMA OOMA INC
Common Stock
M - Exercise 19,157 96,041 24.92 0.90 17,241 86,437
2019-06-12 2019-06-10 4 OOMA OOMA INC
Common Stock
A - Award 9,607 76,884 14.28
2019-05-30 2019-05-28 4 NVRO NEVRO CORP
Common Stock
A - Award 8,564 52,703 19.40
2019-01-08 2019-01-04 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -11,004 0 -100.00
2019-01-08 2019-01-04 4 NVRO NEVRO CORP
Common Stock
M - Exercise 11,004 44,139 33.21 1.44 15,846 63,560
2018-11-02 2018-11-01 4 NVRO NEVRO CORP
Common Stock
F - Taxes -2,457 33,135 -6.90 49.40 -121,376 1,636,869
2018-07-20 2018-07-18 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -7,400 11,004 -40.21
2018-07-20 2018-07-18 4 NVRO NEVRO CORP
Common Stock
M - Exercise 7,400 35,592 26.25 1.44 10,656 51,252
2018-06-07 2018-06-06 4 OOMA OOMA INC
Common Stock
A - Award 10,912 67,277 19.36
2018-05-16 2018-05-14 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -7,000 21,463 -24.59
2018-05-16 2018-05-14 4 NVRO NEVRO CORP
Common Stock
S - Sale X -7,000 28,192 -19.89 76.14 -532,959 2,146,454
2018-05-16 2018-05-14 4 NVRO NEVRO CORP
Common Stock
M - Exercise 7,000 35,192 24.83 18.00 126,000 633,456
2018-03-05 2018-03-01 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -7,000 28,463 -19.74
2018-03-05 2018-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,460 28,192 -4.92 80.87 -118,066 2,279,802
2018-03-05 2018-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5,540 29,652 -15.74 79.90 -442,645 2,369,192
2018-03-05 2018-03-01 4 NVRO NEVRO CORP
Common Stock
M - Exercise 7,000 35,192 24.83 18.00 126,000 633,456
2017-11-16 2017-11-14 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -7,000 35,463 -16.48
2017-11-16 2017-11-14 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 26,000 26,000
2017-11-16 2017-11-14 4 NVRO NEVRO CORP
Common Stock
S - Sale X -7,000 28,192 -19.89 75.11 -525,740 2,117,380
2017-11-16 2017-11-14 4 NVRO NEVRO CORP
Common Stock
M - Exercise 7,000 35,192 24.83 18.00 126,000 633,456
2017-11-16 2017-11-14 4 NVRO NEVRO CORP
Common Stock
A - Award 13,000 28,192 85.57
2017-11-13 2017-11-09 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -4,000 18,404 -17.85
2017-11-13 2017-11-09 4 NVRO NEVRO CORP
Common Stock
M - Exercise 4,000 15,192 35.74 1.44 5,760 21,876
2017-11-03 2017-11-01 4 NVRO NEVRO CORP
Common Stock
F - Taxes -641 11,192 -5.42 88.99 -57,043 995,976
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -204 42,463 -0.48
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -6,144 36,286 -14.48
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -652 43,894 -1.46
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Common Stock
S - Sale X -7,000 11,833 -37.17 82.31 -576,192 974,012
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Common Stock
M - Exercise 204 18,833 1.10 18.00 3,672 338,994
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Common Stock
M - Exercise 6,144 18,629 49.21 3.60 22,118 67,064
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Common Stock
M - Exercise 652 12,485 5.51 3.60 2,347 44,946
2017-06-22 2017-06-20 4 OOMA OOMA INC
Common Stock
A - Award 12,805 56,365 29.40
2017-05-16 2017-05-15 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -7,500 44,546 -14.41
2017-05-16 2017-05-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,306 11,833 -9.94 76.40 -99,782 904,073
2017-05-16 2017-05-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -2,698 13,139 -17.04 75.55 -203,826 992,615
2017-05-16 2017-05-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,496 15,837 -18.08 74.69 -261,126 1,182,910
2017-05-16 2017-05-15 4 NVRO NEVRO CORP
Common Stock
M - Exercise 7,500 19,333 63.38 3.60 27,000 69,599
2017-05-11 2017-05-09 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -5,000 22,404 -18.25
2017-05-11 2017-05-09 4 NVRO NEVRO CORP
Common Stock
M - Exercise 5,000 11,833 73.17 1.44 7,200 17,040
2017-04-05 2017-04-03 4 NVRO NEVRO CORP
Common Stock
S - Sale X -14,297 6,833 -67.66 95.04 -1,358,791 649,410
2017-04-05 2017-04-03 4 NVRO NEVRO CORP
Common Stock
S - Sale X -9,166 21,130 -30.25 94.32 -864,569 1,993,056
2017-04-05 2017-04-03 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,537 30,296 -17.75 93.39 -610,468 2,829,240
2017-03-03 2017-03-01 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -7,500 52,046 -12.60
2017-03-03 2017-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -300 36,833 -0.81 95.77 -28,730 3,527,316
2017-03-03 2017-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -7,200 37,133 -16.24 94.97 -683,801 3,526,610
2017-03-03 2017-03-01 4 NVRO NEVRO CORP
Common Stock
M - Exercise 7,500 44,333 20.36 3.60 27,000 159,599
2016-11-18 2016-11-16 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 27,333 27,333
2016-11-18 2016-11-16 4 NVRO NEVRO CORP
Common Stock
A - Award 6,833 36,833 22.78
2016-11-16 2016-11-15 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -4,185 42,667 -8.93
2016-11-16 2016-11-15 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -3,315 59,546 -5.27
2016-11-16 2016-11-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -2,906 30,000 -8.83 87.55 -254,416 2,626,458
2016-11-16 2016-11-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,734 32,906 -10.19 86.75 -323,942 2,854,747
2016-11-16 2016-11-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -660 36,640 -1.77 85.70 -56,563 3,140,096
2016-11-16 2016-11-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -200 37,300 -0.53 84.16 -16,833 3,139,354
2016-11-16 2016-11-15 4 NVRO NEVRO CORP
Common Stock
M - Exercise 4,185 37,500 12.56 18.00 75,330 675,000
2016-11-16 2016-11-15 4 NVRO NEVRO CORP
Common Stock
M - Exercise 3,315 33,315 11.05 3.60 11,934 119,934
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -5,047 46,852 -9.72
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -2,374 42,430 -5.30
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -79 62,861 -0.13
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -100 30,000 -0.33 98.85 -9,885 2,965,500
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,194 30,100 -9.59 98.09 -313,286 2,952,386
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -4,206 33,294 -11.22 97.39 -409,620 3,242,486
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
M - Exercise 5,047 37,500 15.55 18.00 90,846 675,000
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
M - Exercise 2,374 32,453 7.89 3.60 8,546 116,831
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
M - Exercise 79 30,079 0.26 3.60 284 108,284
2016-06-17 2016-06-16 4 OOMA OOMA INC
Common Stock
A - Award 14,000 43,560 47.36
2016-05-18 2016-05-16 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -10,000 27,404 -26.74
2016-05-18 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -10,000 30,000 -25.00 64.78 -647,847 1,943,541
2016-05-18 2016-05-16 4 NVRO NEVRO CORP
Common Stock
M - Exercise 10,000 40,000 33.33 1.44 14,400 57,600
2016-03-21 2016-03-17 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -25,500 37,404 -40.54
2016-03-21 2016-03-17 4 NVRO NEVRO CORP
Common Stock
M - Exercise 25,500 30,000 566.67 1.44 36,720 43,200
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -10,000 62,904 -13.72
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -100 4,500 -2.17 59.06 -5,906 265,770
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -600 4,600 -11.54 57.68 -34,608 265,324
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,314 5,200 -38.92 56.74 -188,023 295,027
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,100 8,514 -26.69 56.07 -173,803 477,341
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,384 11,614 -10.65 54.81 -75,858 636,574
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,202 12,998 -8.46 53.90 -64,785 700,564
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -300 14,200 -2.07 52.30 -15,689 742,610
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
M - Exercise 10,000 14,500 222.22 1.44 14,400 20,880
2016-03-03 2015-12-29 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -4,500 72,904 -5.81
2016-03-03 2015-12-29 4 NVRO NEVRO CORP
Common Stock
M - Exercise 4,500 4,500 1.44 6,480 6,480
2015-12-03 2015-12-01 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 44,500 44,500
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -4,615 51,899 -8.17
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -4,070 44,804 -8.33
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -869 62,940 -1.36
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -10,446 77,404 -11.89
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,500 0 -100.00 52.01 -78,012
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Common Stock
S - Sale X -18,500 1,500 -92.50 51.24 -947,877 76,855
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Common Stock
M - Exercise 4,615 20,000 30.00 18.00 83,070 360,000
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Common Stock
M - Exercise 4,070 15,385 35.97 3.60 14,652 55,386
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Common Stock
M - Exercise 869 11,315 8.32 3.60 3,128 40,734
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Common Stock
M - Exercise 10,446 10,446 1.44 15,042 15,042
2015-07-20 2015-07-16 4 OOMA OOMA INC
Common Stock
A - Award 9,615 29,560 48.21
2015-07-16 3 OOMA OOMA INC
Common Stock
39,890
2015-07-16 3 OOMA OOMA INC
Common Stock
39,890
2014-11-07 2014-11-05 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 56,514 56,514
2014-06-02 2014-05-29 4 DDXS diaDexus, Inc.
Stock Option (Right to Buy)
A - Award 60,000 60,000
2013-08-08 2013-08-06 4 DDXS diaDexus, Inc.
Stock Option (Right to Buy)
A - Award 60,000 60,000
2013-08-08 2013-08-06 4 DDXS diaDexus, Inc.
Common Stock
A - Award 6,500 6,500
2012-09-24 2012-09-20 4 DDXS diaDexus, Inc.
Common Stock
A - Award 60,000 60,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)